Bloxiverz

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 51754-1200
  • Package NDC 51754-1200-3
  • Application number NDA204078
  • SPL ID f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47
  • SPL set ID d2f55643-2b0d-4ef9-a9d8-b7138b314372
  • UNII 98IMH7M386
  • RxCUI 311935
  • RxCUI 311936
  • RxCUI 1429282
  • RxCUI 1429284
  • RxCUI 1668225
  • RxCUI 2673236

What the source publishes

Labeler
Exela Pharma Sciences, LLC
Active ingredients
Neostigmine Methylsulfate
Form
INJECTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:51754-1200_f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47
{
  "name": "Bloxiverz",
  "splId": "f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47",
  "labels": [
    {
      "setId": "d2f55643-2b0d-4ef9-a9d8-b7138b314372",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2f55643-2b0d-4ef9-a9d8-b7138b314372",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=d2f55643-2b0d-4ef9-a9d8-b7138b314372"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "Exela Pharma Sciences, LLC",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 SYRINGE, PLASTIC in 1 CARTON (51754-1200-3)  / 5 mL in 1 SYRINGE, PLASTIC",
      "package_ndc": "51754-1200-3",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20231231"
    }
  ],
  "productId": "51754-1200_f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "51754-1200",
  "deaSchedule": null,
  "genericName": "Neostigmine Methylsulfate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NEOSTIGMINE METHYLSULFATE",
      "strength": "1 mg/mL"
    }
  ],
  "applicationNumber": "NDA204078",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20231106",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "98IMH7M386"
    ],
    "rxcui": [
      "311935",
      "311936",
      "1429282",
      "1429284",
      "1668225",
      "2673236"
    ],
    "spl_set_id": [
      "d2f55643-2b0d-4ef9-a9d8-b7138b314372"
    ],
    "manufacturer_name": [
      "Exela Pharma Sciences, LLC"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:51754-1200_f9ddedaa-a4a1-4fa2-8a3e-a3bb3abdde47"